創傷和急診醫學科
抗凝管理和逆轉
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. （開啟新視窗）
來源: Lancet 2015;385(9982):2077-87.
檢索: PubMed 25728933
DOI碼: 10.1016/S0140-6736(14)61685-8
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. （開啟新視窗）
來源: Am J Hematol 2012;87 Suppl 1:S141-5.
檢索: PubMed 22473649
DOI碼: 10.1002/ajh.23202
Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. （開啟新視窗）
來源: J Thromb Haemost 2011;9(9):1705-12.
檢索: PubMed 21729240
DOI碼: 10.1111/j.1538-7836.2011.04432.x
Emergency reversal of warfarin anticoagulation. （開啟新視窗）
來源: CMAJ 2010;182(18):2004.
檢索: PubMed 21078740
DOI碼: 10.1503/cmaj.100983
Management of anticoagulation agents in trauma patients. （開啟新視窗）
來源: Clin Lab Med 2014;34(3):563-74.
檢索: PubMed 25168942
DOI碼: 10.1016/j.cll.2014.06.013
Idarucizumab for dabigatran reversal - full cohort analysis. （開啟新視窗）
來源: N Engl J Med 2017;377(5):431-41.
檢索: PubMed 28693366
DOI碼: 10.1056/NEJMoa1707278
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. （開啟新視窗）
來源: Anesth Analg 2011;113(4):703-10.
檢索: PubMed 21890888
DOI碼: 10.1213/ANE.0b013e318228c690
Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. （開啟新視窗）
來源: World Neurosurg 2014;81(1):110-5.
檢索: PubMed 23220122
DOI碼: 10.1016/j.wneu.2012.12.002